TMDX: TransMedics Group Inc Company Sales Revenue

Product sales dynamics for TransMedics Group (TMDX) demonstrate growth, with the final metric value standing at 0.73. High barriers to entry are established by patents and FDA certifications. Monopoly air transport and a stable cash flow ensure business resilience. The foundation of success is a team of bioengineers united by a mission to save lives through innovative organ preservation.

Revenue and Sales Volume: TransMedics Group, Inc. (TMDX) for 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for TransMedics Group, Inc. (TMDX)

- current price and projected stock value:

Share Price transmedics.com|TMDX - Consensus Target

- market capitalization information:

Market Value TransMedics Group, Inc.|TMDX - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share TransMedics|TMDX - Book Capitalization|Market-to-Book Ratio transmedics.com|TMDX - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

TMDX - Net Income|Expected Net Income TransMedics Group|TMDX - P/E Multiple|Projected Price to Earnings Ratio TransMedics Group|TMDX - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple TransMedics Group, Inc.|TMDX - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) TransMedics|TMDX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months transmedics.com|TMDX - Earnings per share growth in current year|Net earnings per share change forecast for next year TransMedics Group

- company sales and revenue statistics:

TMDX - Company Revenue|Company Future Sales Volume TransMedics Group, Inc.|TMDX - P/S Multiple|Market Cap to Future Revenue Ratio TransMedics Group, Inc.

Summary company analysis:TMDX TransMedics Organ Care System

For transplantology leader TransMedics Group (TMDX), which holds exclusive FDA approval for the OCS system, a steady stream of revenue from technology implementation serves as the primary indicator of market dominance. By analyzing the company's commercial revenue trends, investors assess the stability of cash inflows relative to historical averages, where any systematic deviations signal rising risks of capital drawdown and the need to revise the investment thesis.

Key competitors